Your browser doesn't support javascript.
loading
Targeting immunogenic cell death for glioma immunotherapy.
Mishchenko, Tatiana A; Turubanova, Victoria D; Gorshkova, Ekaterina N; Krysko, Olga; Vedunova, Maria V; Krysko, Dmitri V.
Afiliação
  • Mishchenko TA; Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Turubanova VD; Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia; Neuroscience Research Institute, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Gorshkova EN; Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Krysko O; Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Vedunova MV; Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Krysko DV; Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Cancer Research Institute Ghent, Ghent, Belgium. Electronic address: dmitri.krysko@ugent.be.
Trends Cancer ; 10(1): 8-11, 2024 01.
Article em En | MEDLINE | ID: mdl-37973489
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioma / Antineoplásicos Limite: Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioma / Antineoplásicos Limite: Humans Idioma: En Revista: Trends Cancer Ano de publicação: 2024 Tipo de documento: Article